These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26966351)

  • 1. miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism.
    Tang XY; Zheng W; Ding M; Guo KJ; Yuan F; Feng H; Deng B; Sun W; Hou Y; Gao L
    Drug Des Devel Ther; 2016; 10():571-83. PubMed ID: 26966351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting glucose metabolism in chondrosarcoma cells enhances the sensitivity to doxorubicin through the inhibition of lactate dehydrogenase-A.
    Hua G; Liu Y; Li X; Xu P; Luo Y
    Oncol Rep; 2014 Jun; 31(6):2727-34. PubMed ID: 24789077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance.
    Kumari R; Li H; Haudenschild DR; Fierro F; Carlson CS; Overn P; Gupta L; Gupta K; Nolta J; Yik JH; Di Cesare PE
    Carcinogenesis; 2012 Nov; 33(11):2076-83. PubMed ID: 22847180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-100 resensitizes resistant chondrosarcoma cells to cisplatin through direct targeting of mTOR.
    Zhu Z; Wang CP; Zhang YF; Nie L
    Asian Pac J Cancer Prev; 2014; 15(2):917-23. PubMed ID: 24568519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Src by microRNA-23b increases the cisplatin sensitivity of chondrosarcoma cells.
    Huang K; Chen J; Yang MS; Tang YJ; Pan F
    Cancer Biomark; 2017; 18(3):231-239. PubMed ID: 28085008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma.
    Bao X; Ren T; Huang Y; Wang S; Zhang F; Liu K; Zheng B; Guo W
    J Exp Clin Cancer Res; 2016 Aug; 35(1):129. PubMed ID: 27576314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-125b Functions as a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma.
    Wang F; Yu D; Liu Z; Wang R; Xu Y; Cui H; Zhao T
    Technol Cancer Res Treat; 2016 Dec; 15(6):NP105-NP112. PubMed ID: 26744308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic fibroblast growth factor promotes doxorubicin resistance in chondrosarcoma cells by affecting XRCC5 expression.
    Hsieh MJ; Huang C; Lin CC; Tang CH; Lin CY; Lee IN; Huang HC; Chen JC
    Mol Carcinog; 2020 Mar; 59(3):293-303. PubMed ID: 31916307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
    Zhang Y; Duan G; Feng S
    Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ethanol on the anticancer function of doxorubicin in JJ012 cells.
    Huang H; Li Y; Wu M; Luo J; Nie J; Hou B; He Q; Diao Y; Qi L; Zhao Y; Liu Y; Yang D; Zhou L
    Future Oncol; 2018 Jun; 14(13):1285-1297. PubMed ID: 29774752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis.
    Zhou B; Li L; Li Y; Sun H; Zeng C
    Biomed Pharmacother; 2018 Oct; 106():850-857. PubMed ID: 30119255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-631 Resensitizes Doxorubicin-Resistant Chondrosarcoma Cells by Targeting Apelin.
    Chen JC; Shih HC; Lin CY; Guo JH; Huang C; Huang HC; Chong ZY; Tang CH
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance-1 and p-glycoprotein in human chondrosarcoma cell lines: expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance.
    Wyman JJ; Hornstein AM; Meitner PA; Mak S; Verdier P; Block JA; Pan J; Terek RM
    J Orthop Res; 1999 Nov; 17(6):935-40. PubMed ID: 10632461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of microRNA-125b sensitizes human hepatocellular carcinoma cells to 5-fluorouracil through inhibition of glycolysis by targeting hexokinase II.
    Jiang JX; Gao S; Pan YZ; Yu C; Sun CY
    Mol Med Rep; 2014 Aug; 10(2):995-1002. PubMed ID: 24865963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.
    Xie X; Hu Y; Xu L; Fu Y; Tu J; Zhao H; Zhang S; Hong R; Gu X
    Tumour Biol; 2015 Sep; 36(9):7185-94. PubMed ID: 25894378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced sensitivity to tumor necrosis factor-alpha in doxorubicin-resistant tumor cell lines due to down-regulated c-erbB2.
    Sleijfer S; Asschert JG; Timmer-Bosscha H; Mulder NH
    Int J Cancer; 1998 Jul; 77(1):101-6. PubMed ID: 9639400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphiregulin enhances cell migration and resistance to doxorubicin in chondrosarcoma cells through the MAPK pathway.
    Chen JC; Huang C; Lee IN; Wu YP; Tang CH
    Mol Carcinog; 2018 Dec; 57(12):1816-1824. PubMed ID: 30230033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
    Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
    Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA-497 Negatively Regulates the Growth and Motility of Chondrosarcoma Cells by Targeting Cdc25A.
    Lu Y; Li F; Xu T; Sun J
    Oncol Res; 2016; 23(4):155-63. PubMed ID: 27053344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.